10 years of research on IPS e.max

A new Scientific Report from Ivoclar Vivadent for the first time brings together the most important studies on IPS e.max that have been conducted in the course of the past ten years. More than 20 clinical in-vivo as well as further in-vitro studies have been compiled and are presented in a clearly structured manner.

IPS e.max is an innovative all-ceramic restorative system which comprises lithium disilicate glass-ceramic and zirconia materials for both pressing and milling. The system is complemented by a nano-fluorapatite glass-ceramic.

Since the initiation of its development more than a decade ago, the IPS e.max system has been scientifically investigated on an ongoing basis. With their studies, many reputable experts have contributed to what has become a valuable resource for scientific data on IPS e.max. The most important study results, including details on test methods, successful cases and survival rates, can be found in the new, clearly arranged IPS e.max Scientific Report.

The Report summarizes data on the clinical performance of IPS e.max that cover longer periods of time: up to five years for zirconia and up to ten years for lithium disilicate. In addition, the overall survival rate for the entire system was calculated by combining the survival rates of IPS e.max Press (six studies), IPS e.max CAD (6 studies) and IPS e.max ZirCAD (8 studies). These 20 studies involved a total of 1071 restorations. The overall survival rate for the IPS e.max system was 96.8%.

Apart from this result on the IPS e.max system as a whole, the Scientific Report also contains the results of clinical trials that focussed on individual components. IPS e.max Press and IPS e.max CAD, IPS e.max ZirCAD as well as related products such as IPS e.max ZirPress and IPS e.max Ceram were examined.

The IPS e.max Scientific Report Vol. 01/2001-2011 is available for download at www.ivoclarvivadent.com/en/all/ips-emax-scientific-report